Location · Cleveland, OH
Clinical trials in Cleveland, OH
388 recruiting studies have a site in the Cleveland area, and 87 of them accept healthy volunteers. The area includes Beachwood, Mayfield Heights, Independence, Westlake, Parma, Lakewood and nearby cities.
388 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 4
Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
Angiodynamics, Inc.
- Location
- Phoenix, AZ + 8 other US sites
- Eligibility basics
- Any age listed
- Recruiting
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Concept Medical Inc.
- Location
- Scottsdale, AZ + 24 other US sites
- Eligibility basics
- Ages 21+
- RecruitingPhase 3
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
ReGenTree, LLC
- Location
- Laguna Hills, CA + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
AbbVie
- Location
- Huntington Beach, CA + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC
- Location
- Duarte, CA + 25 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Treatment of Moderate to Severe Refractory Crohn's Disease
Tr1X, Inc.
- Location
- Scottsdale, AZ + 12 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Trisol System EFS Study
Trisol Medical
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
EnCompass Technologies, Inc.
- Location
- Indianappolis, IN + 4 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Phoenix, AZ + 34 other US sites
- Eligibility basics
- Ages 12–18
- Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Endospan Ltd.
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Medicure
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
Cionic, Inc.
- Location
- Cleveland, OH
- Eligibility basics
- Ages 22–75
- Recruiting
VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions
VasoStar, LLC
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
PharmaIN
- Location
- Chandler, AZ + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
BioRestorative Therapies
- Location
- Santa Monica, CA + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Impax Laboratories, LLC
- Location
- Little Rock, AR + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Mobile, AL + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
aTyr Pharma, Inc.
- Location
- Los Angeles, CA + 12 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study
ReVivo Medical, Corp.
- Location
- Union, NJ + 3 other US sites
- Eligibility basics
- Ages 22–79
- RecruitingPhase 1
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
Ascentage Pharma Group Inc.
- Location
- Duarte, CA + 6 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Concept Medical Inc.
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18–110
- Recruiting
Retrospective-Prospective PNS Study
Curonix LLC
- Location
- Cleveland, OH
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Tenaya Therapeutics
- Location
- San Francisco, CA + 6 other US sites
- Eligibility basics
- Ages 18–65